Clinical trial
The Effect of Transepicardial Augmentation on Transseptal Autologous CD 133+ Bone Marrow Cell Implantation to Myocardial Perfusion in Patient Following Coronary Artery Bypass Grafting
NCT02870933 is registered in ClinicalTrials.gov with National Cardiovascular Center Harapan Kita Hospital Indonesia as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Effect of Transepicardial Augmentation on Transseptal Autologous CD 133+ Bone Marrow Cell Implantation to Myocardial Perfusion in Patient Following Coronary Artery Bypass Grafting
- Lead sponsor
- National Cardiovascular Center Harapan Kita Hospital Indonesia
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- January 31, 2016
- Completion date
- April 30, 2019
- Enrollment
- 30 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.